1 Followers
25 Following
Abhijit

Abhijit

Pneumococcal Vaccines Market to Surpass US$ 13,194.3 Million by 2026

Pharmaceutical companies are reluctant to invest in production of new vaccines, owing to very less returns.

Pneumococcal Vaccines Market to Surpass US$ 13,194.3 Million by 2026

Pharmaceutical companies are reluctant to invest in production of new vaccines, owing to very less returns.

Pneumococcal Vaccines Market to Surpass US$ 13,194.3 Million by 2026

Pharmaceutical companies are reluctant to invest in production of new vaccines, owing to very less returns.

Pneumococcal Vaccines Market to Surpass US$ 13,194.3 Million by 2026

Pharmaceutical companies are reluctant to invest in production of new vaccines, owing to very less returns.

Pneumococcal Vaccines Market to Surpass US$ 13,194.3 Million by 2026

Pharmaceutical companies are reluctant to invest in production of new vaccines, owing to very less returns.

Pneumococcal Vaccines Market Expand Steadily Potential Growth by 2018-2026

Pharmaceutical companies are reluctant to invest in production of new vaccines, owing to very less returns.

Oncology Drugs Market Boosting The Growth Worldwide 2026

Increasing drug approvals and robust pipeline for novel therapeutic agents are some of the key factors driving the oncology drugs market growth.

Oncology Drugs Market Boosting The Growth Worldwide 2026

Increasing drug approvals and robust pipeline for novel therapeutic agents are some of the key factors driving the oncology drugs market growth.

Oncology Drugs Market 2019 | Develop Rapidly by Top Players Hoffmann-La Roche AG

Increasing drug approvals and robust pipeline for novel therapeutic agents are some of the key factors driving the oncology drugs market growth. For instance, in August 2017, Tisagenlecleucel (Kymriah), a drug developed by Novartis was approved by the U.S. Food and Drug Administration (FDA) for the treatment of pediatric and young adults with refractory or relapsed Acute Lymphoblastic Leukemia (ALL). Moreover, increasing prevalence of various types of cancer is also fueling the oncology drugs market growth. For instance, according to a report by National Cancer Institute, 2016, around 16.8 million new cases of cancer are diagnosed in the U.S. every year, with around 595,690 deaths from the disease and the number of people with cancer is expected to increase to 19 million by 2024.

Request Sample Copy of this Report: http://bit.ly/2IhrcI7

However, high cost of cancer drugs and adoption of alternative treatment options such as surgery and radiation therapy are major factors hindering the oncology drugs market growth. Several blockbuster oncology drugs in the market are expected to lose patent during 2018-2020, which is turn acts as an opportunities for emerging players in the global oncology drugs market.

Oncology Drugs Market Emerging Growth, Outlook and Opportunity Analysis, 2018–2026

Increasing drug approvals and robust pipeline for novel therapeutic agents are some of the key factors driving the oncology drugs market growth.

Oncology Drugs Market Insights | Research and Development By 2018-2026

Increasing drug approvals and robust pipeline for novel therapeutic agents are some of the key factors driving the oncology drugs market growth.

Oncology Drugs Market Insights | Research and Development By 2018-2026

Increasing drug approvals and robust pipeline for novel therapeutic agents are some of the key factors driving the oncology drugs market growth.

Microneedling Devices Market Size, Share, Outlook, and Analysis, 2018-2026

Increasing incidences of uneven skin tone and skin discoloration are expected to boost growth of the microneedling devices market

Glucose Sensor Market Size, Share, Outlook, and Analysis, 2018-2026

Glucose sensors are inserted under skin to measure glucose (sugar) levels. These sensors are connected wirelessly to the continuous glucose monitoring system.

Oncology Drugs Market 2019 | Develop Rapidly by Top Players Hoffmann-La Roche AG

Increasing drug approvals and robust pipeline for novel therapeutic agents are some of the key factors driving the oncology drugs market growth.

Oncology Drugs Market Size, Share, Outlook, and Analysis, 2018-2026

Increasing drug approvals and robust pipeline for novel therapeutic agents are some of the key factors driving the oncology drugs market growth.